References
Hungria VTM, Crusoe EQ, Maiolino A, Bittencourt R, Fantl D, Maciel JFR, Pessoa de Magalhaes RJ, Almeida MSS, Cury P, Hisgashi F, Peres AL, Chiattone CS (2016) Phase 3 trial of three thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant-eligible. Ann Hematol 95:271–278
National Institute for Health and Care Excellence (2011). Bortezomib and thalidomide for the first-line treatment of multiple myeloma (NICE (Multiple) Technology Appraisal Guidance No. 228). Available at: https://www.nice.org.uk/guidance/TA228 [accessed 16th October 2019]
Scottish Medicines Consortium (2009), Medicines advice: thalidomide (SMC 525/08). Available at: https://www.scottishmedicines.org.uk/medicines-advice/thalidomide-pharmion-fullsubmission-52508/ [accessed 16th October 2019]
Morgan GJ, Davies FE, Gregory WM (2011) Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation. Blood 118:1231–1238
Acknowledgements
The authors are grateful to Christine Crearie and colleagues in the West of Scotland Cancer Network and West of Scotland Haematology Audit Group for support and access to patient data.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Soutar, R., Steel, M., Donaldson, A. et al. Comparison of thalidomide-containing regimens in patients with newly diagnosed multiple myeloma not transplant eligible. Ann Hematol 99, 905–906 (2020). https://doi.org/10.1007/s00277-020-03919-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-020-03919-5